134 related articles for article (PubMed ID: 6768290)
1. Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin.
Gómez F; de la Cueva R; Wauters JP; Lemarchand-Béraud T
Am J Med; 1980 Apr; 68(4):522-30. PubMed ID: 6768290
[No Abstract] [Full Text] [Related]
2. [Sexuality changes in a hemodialysis patient with hyperprolactinemia: therapeutic possibilities].
Mondaini F; Gavazzi M; Benelli R; De Maio P
Riv Ital Ginecol; 1980; 59 Suppl():93-6. PubMed ID: 6813937
[No Abstract] [Full Text] [Related]
3. [Reproductive dysfunction in women of reproductive age undergoing hemodialysis].
Matuszkiewicz-Rowińska J
Pol Arch Med Wewn; 2003 Oct; 110(4):1109-16. PubMed ID: 14699668
[No Abstract] [Full Text] [Related]
4. Testosterone levels after bromocriptine treatment in patients undergoing long-term hemodialysis.
Vircburger MI; Prelević GM; Perić LA; Knezević J; Djukanović L
J Androl; 1985; 6(2):113-6. PubMed ID: 3921506
[TBL] [Abstract][Full Text] [Related]
5. [Gonadal dysfunction in the male with chronic renal insufficiency].
Joven J; Villabona C; Espinel E
Med Clin (Barc); 1986 Feb; 86(6):249-53. PubMed ID: 3084891
[No Abstract] [Full Text] [Related]
6. Impact of oral zinc therapy on the level of sex hormones in male patients on hemodialysis.
Jalali GR; Roozbeh J; Mohammadzadeh A; Sharifian M; Sagheb MM; Hamidian Jahromi A; Shabani S; Ghaffarpasand F; Afshariani R
Ren Fail; 2010 May; 32(4):417-9. PubMed ID: 20446777
[TBL] [Abstract][Full Text] [Related]
7. [Sexual dysfunction among 78 Moroccan male hemodialysis patients: clinical and endocrine study].
Zamd M; Farh M; Hbid O; Zabari M; Benghanem Gharbi M; Ramdani B; Zaïd D; El Abbadi N; Lalaoui K; Belhouari A; Hassan Tahri E
Ann Endocrinol (Paris); 2004 May; 65(3):194-200. PubMed ID: 15277975
[TBL] [Abstract][Full Text] [Related]
8. Luteal phase dysfunction.
Dizerega GS; Ross GT
Clin Obstet Gynaecol; 1981 Dec; 8(3):733-51. PubMed ID: 6797773
[No Abstract] [Full Text] [Related]
9. Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study.
Zhang Y; Tang Z; Ruan Y; Huang C; Wu J; Lu Z; Li W; Tang Y; Liu J; She J; Wang TT; Zhu Y; Teng ZW; Zeng Y
Med Sci Monit; 2018 Dec; 24():9136-9143. PubMed ID: 30554232
[TBL] [Abstract][Full Text] [Related]
10. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
Davajan V; Kletzky O; March CM; Roy S; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human erythropoietin (r-HuEPO) therapy on plasma FT3, FT4, TSH, FSH, LH, free testosterone and prolactin levels in hemodialysis patients.
Yeksan M; Tamer N; Cirit M; Türk S; Akhan G; Akkus I; Erkul I
Int J Artif Organs; 1992 Oct; 15(10):585-9. PubMed ID: 1428205
[TBL] [Abstract][Full Text] [Related]
12. Clinical study of male sexual activity on chronic hemodialysis after renal transplantation.
Ishii T; Nagano T; Hara Y; Negita M; Nishioka T; Akiyama T; Kurita T
Transplant Proc; 1996 Jun; 28(3):1646-8. PubMed ID: 8658820
[No Abstract] [Full Text] [Related]
13. [Hypothalamo-hypophyseo-gonadal axis in individuals with chronic renal insufficiency subjected to hemodialysis].
Mendoza C; Carreras A; Ruiz E; Ortega E; Hervás J; Osorio C
Rev Esp Fisiol; 1985 Dec; 41(4):443-6. PubMed ID: 3938041
[TBL] [Abstract][Full Text] [Related]
14. [Prolactin and luteal phase defect (author's transl)].
Mühlenstedt D; Meissner M; Schneider HP
Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):580-7. PubMed ID: 467952
[No Abstract] [Full Text] [Related]
15. [Plasma levels of follicle-stimulating and luteinizing hormones, prolactin and estradiol in women with chronic kidney failure on programmed hemodialysis].
Tanchev S; Tanchev I; Maleeva A; Visheva N
Vutr Boles; 1981; 20(5):65-70. PubMed ID: 6798762
[TBL] [Abstract][Full Text] [Related]
16. Sexual dysfunction in women during dialysis and after renal transplantation.
Filocamo MT; Zanazzi M; Li Marzi V; Lombardi G; Del Popolo G; Mancini G; Salvadori M; Nicita G
J Sex Med; 2009 Nov; 6(11):3125-31. PubMed ID: 19627463
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine and the hypothalamic hypophyseal function in patients with chronic renal failure on chronic hemodialysis.
Ramirez G; Butcher DE; Newton JL; Brueggemeyer CD; Moon J; Gomez-Sanchez C
Am J Kidney Dis; 1985 Aug; 6(2):111-8. PubMed ID: 4025330
[TBL] [Abstract][Full Text] [Related]
18. Prolactin and thyrotropin in thyroid diseases: lack of evidence for a physiological role of thyrotropin-releasing hormone in the regulation of prolactin secretion.
L'Hermite M; Robyn C; Golstein J; Rothenbuchner G; Birk J; Loos U; Bonnyns M; Vanhaelst L
Horm Metab Res; 1974 May; 6(3):190-5. PubMed ID: 4209662
[No Abstract] [Full Text] [Related]
19. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
[No Abstract] [Full Text] [Related]
20. Endocrine effects of erythropoietin.
Carlson HE; Graber ML; Gelato MC; Hershman JM
Int J Artif Organs; 1995 Jun; 18(6):309-14. PubMed ID: 8593965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
